
Sanofi has started construction of a €70 million manufacturing facility in Algeria that will be the company’s largest site in …



In a blow to its diabetes pipeline, Sanofi has withdrawn a new drug application (NDA) for lixisenatide in the US …

Western pharma companies caught up in Chinese probes over corruption are being discriminated against, according to a European business lobby …

Sanofi’s once-daily multiple sclerosis pill Aubagio has been authorised by European regulators, paving the way for it to continue its …



Sanofi has announced the appointments of Carsten Hellmann and David Meeker to its executive committee team. Hellmann (pictured) joins Sanofi …

Sanofi has been hit by generic erosion for key drugs in the second quarter, but the firm is confident it …

Sanofi’s multiple sclerosis drug Lemtrada has received a positive recommendation from the CHMP, meaning a European approval is likely just …

Chief executive of Sanofi Christopher Viehbacher has been elected to serve as president of the European Federation of Pharmaceutical Industries …